Standards & guidance

Filter Standards and Guidance documents

Page 11 of 13

FSRH Guideline-related CPD Q&A: Fertility Awareness Methods (June 2015)

15 March 2016

1 CPD credit can be claimed for reading the guidance and 1 CPD credit can be claimed for answering the questions.

This resource is available to members/candidates of FSRH.

Please read this guidance document in conjunction with any relevant clinical statements for this topic.

FSRH Guideline-related CPD Q&A: Problematic Bleeding with Hormonal Contraception (July 2015)

15 March 2016

Claiming CPD credits 1 CPD credit can be claimed for reading the guidance. 1 CPD credit can be claimed for answering the questions.

This resource is available to members/candidates of FSRH.

This document is up-to-date

FSRH CEU Statement: NICE Menopause Guideline 2015 (November 2015)

01 November 2015

The FSRH welcomes the publication of the new NICE Menopause Guideline in November 2015 which includes 64 recommendations relevant to UK clinical practice.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

This document is up-to-date

FSRH New Product Review: Eloine Daylette (November 2015)

01 November 2015

How effective is 20mcgEE/3mgDRSP as contraception?20mcgEE/3mg DRSP is of comparable effectiveness to other combined oral contraceptives. [1,2,3] A large US observational study reports lower failure rates amongst users of a 24/4 EE/DRSP regimen than a 21/7 EE/DRSP regimen. The study also suggests greater contraceptive effectiveness of a 24/4 EE/DRSP regimen than with a 24/4 regimen containing EE in combination with norethisterone.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

This document is up-to-date

FSRH CEU Statement: Response to the BMJ paper by Mao et. al. (October 2015)

01 October 2015

A large observational study from the United States found that the risk of unintended pregnancy after Essure sterilisation was similar to that after surgical sterilisation. However just over 2% of women who had Essure sterilisation required a further operation related to the sterilisation procedure within a year.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

This document is up-to-date

FSRH CEU Statement: Response to the FDA Review of Essure® (October 2015)

01 October 2015

Essure® is a form of female sterilisation which involves the hysteroscopic insertion of flexible micro-inserts into the proximal section of the fallopian tubes and is undertaken without general anaesthesia.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

This document is up-to-date

FSRH Clinical Guideline: Barrier Methods for Contraception and STI Prevention (August 2012, amended October 2015)

01 October 2015

This guidance provides evidence-based recommendations and good practice points for health professionals on the use of barrier methods for contraception and STI prevention. It is intended for any health care professional or health service providing contraception or conception advice in the UK.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

Please read this guidance document in conjunction with any relevant clinical statements for this topic.

FSRH CEU Statement: Self-Administration of Sayana Press® (September 2015)

01 September 2015

The CEU supports the self administration of Sayana Press® because of its potential benefits to women and services. It offers women greater choice and more autonomy over their contraception and fertility.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

This document is up-to-date

FSRH CEU Statement: CEU response to published study: Chlamydia screening for pregnant women aged 16–25 years attending an antenatal service (August 2015)

01 August 2015

The BJOG: An International Journal of Obstetrics and Gynaecology today published an Australian study that considers the cost effectiveness of routine screening for Chlamydia trachomatis in all pregnant women aged 16 to 25 years.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

This document is up-to-date